Latest Articles

Featuring research from the Doudna laboratory, the University of Harvard and the Center for Advanced Bioenergy and Bioproducts Innovation, this round-up piece discusses the latest research advancements in CRISPR technology.

In this article, we consider what natural killer (NK) cells are, how they are generated, their function in the body and conditions related to them.

Some types of cancer are still extremely challenging to successfully treat. Once the disease has spread, it is very hard to cure. This article will explore the various types of tumor heterogeneity, how heterogeneity can impact treatment resistance and its influence on precision medicine.

Predatory conferences mimic legitimate academic events but lack essential academic standards. Susan Veldsman, Director of the Scholarly Publication Unit at ASSAf, scrutinizes these deceptive practices in Technology Networks’ Ask Me Anything session.

Our education system fails to furnish young people who will go on to be decision-makers, at home and in the workplace, with an adequate grasp of microbiology. The International Microbiology Literacy Initiative (IMiLI) is hoping to address this.

Join us as we explore how innovation, ethics and even aesthetics look set to influence the landscape of life science research, creating new possibilities for treating human diseases, feeding our growing population and nurturing the scientists of the future.

The publishing landscape for scientists is changing, and there is now a plethora of options available, whether commercial or society-associated, from which to choose. This article explores where society journals sit in our scientific publishing picture and how publishing fits with societies.

Neil Ward explores how genomic sequencing can help to strengthen global surveillance of AMR, protect existing antimicrobial therapies and safeguard the health of communities worldwide.

A novel technique, combining long-read sequencing and machine learning, enables rapid sterility testing in T-cell cultures. This will help accelerate treatment delivery and improve outcomes for patients undergoing cell therapy for incurable diseases.

In this article, the latest challenges in interpreting complex genomic cancer profiles and the improvements needed to overcome them are discussed.